Correction to: Nature Medicine https://doi.org/10.1038/s41591-021-01573-6, published online 9 December 2021.
In the version of this article initially published, there were errors in the inset graph to Fig. 2a, where the inset had the graph lines and symbols for the 0.3 mg kg–1 and the 0.6 mg kg–1 switched, and the wrong data were shown for the 0.6 mg kg–1 in the inset. The labels and plots have been corrected in the HTML and PDF versions of the article. The original and corrected Fig 2a graphs are shown below.
Original and corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
August, A., Attarwala, H.Z., Himansu, S. et al. Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus. Nat Med 28, 1095–1096 (2022). https://doi.org/10.1038/s41591-022-01817-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-01817-z
